Related by context. Frequent words. (Click for all words.) 85 Takeda Kyowa Hakko Kirin 81 Idec Roche 70 Medtronic Novartis Biogen 66 Initiates Phase II 64 GlaxoSmithKline Bristol Myers 63 Inc Therapeutic Competitors 62 Genentech Bayer CuraGen 62 Presents Positive 62 Welcomes Analyst Initiation 62 NV Organon 62 Bayer HealthCare subsidiary 61 Files Shelf Registration Statement 61 Transcept Pharmaceuticals 61 www.vivus.com 61 NASDAQ CRXL 61 Completes Enrollment 61 Wyeth Pharmaceuticals Wyeth 61 Inc. NASDAQ TRGT 61 Genentech GlaxoSmithKline 61 developing Zerenex TM 61 Vytorin combines 61 Receives Orphan Drug Designation 60 DWS Trust 60 www.syntapharma.com 60 Antigen Express website 60 Signs License Agreement 60 please visit http:/www.supergen.com 60 Commences Phase 60 addressing idiopathic pulmonary 60 Inc. Nasdaq IMGN 59 Nasdaq VRTX 59 www.exelixis.com 59 visit www.PAREXEL.com 59 Announces Initiation 59 R sorafenib tablets 59 Inc. Nasdaq SEPR 59 Crucell NV Euronext 59 By Thomas Gryta 59 Connetics Corporation 59 Regulus Therapeutics LLC 59 Jumps Higher 59 Corp. Nasdaq GENZ 59 Nasdaq ENMD 58 produces Chrysler Jeep 58 Exploit collaboration 58 Introducing Leading Microcap 58 Idera Pharmaceuticals 58 Develop Novel 58 Bearish Pressure Building 58 Joseph Levi Esq 58 TSX IGM group 58 www.caliperLS.com 58 manufactures Cialis 58 * Azixa 58 Therapeutic Competitors 58 MultiCell Technologies 58 PUBLIC WEBSITE WWW.FITCHRATINGS.COM 58 Inc. Nasdaq SUPG 58 Staff Writer jamieb@nwanews.com 57 Biodefense Division 57 VERBINDLICH IST AUSSCHLIESSLICH DIE 57 www.celgene.com 57 Copegus R 57 PINNACLEDIGEST.COM S PAST PERFORMANCE 57 AS ESTIMATE ANTICIPATE BELIEVE 57 Meets Primary Endpoint 57 MAY CONTAIN FORWARD LOOKING 57 Merrimack Pharmaceuticals 57 FREE Whitepaper 57 Cubist 57 EPIX Pharmaceuticals Inc. 56 AXYS Design Automation 56 Regulus Therapeutics 56 Regulatory Disclosure 56 FDA Accepts 56 CONTAINS FORWARD LOOKING STATEMENTS 56 ticker symbol OPERA 56 Ariba logo AribaLIVE 56 Bayhill Therapeutics 56 Blitz Weinhard Brewing 56 Patient Enrollment 56 assimilating acquired 56 Initiates Phase 56 Eyetech Pharmaceuticals 56 By Neil Osterweil 56 Invites Investors 56 OR SIMILAR STATEMENTS ARE 56 Paramount Pictures Paramount Vantage 56 IN ANY TRANSCRIPT 56 Nasdaq ISIS 56 Report companiesandmarkets.com adds 56 Archemix Corp. 56 Agios Pharmaceuticals 56 PYMX 56 OncoMed Pharmaceuticals 56 Nasdaq ENZN 55 gets USFDA nod 55 GlaxoSmithKline plc NYSE 55 Quark Pharmaceuticals 55 email info@bigbandnet.com 55 Inc. Nasdaq TRMS